{
  "experiment_id": "c2f33aa0d62538582d912f271db41825",
  "task_name": "narrowing_of_broad_synonyms",
  "task_hash": "fad80e5ef0b6a35a2e224357c530fdf1",
  "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
  "system_instructions": "You are a metadata curation assistant. Your task is to help improve and correct metadata \naccording to the specific instructions provided for each task. Be precise, accurate, and \nfollow the guidelines carefully.\n",
  "temperature": 0.1,
  "thinking": false,
  "timestamp": "2025-11-13T04:08:27.716700",
  "task_result": {
    "task_name": "narrowing_of_broad_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis",
          "assay": "DNA sequencing",
          "tumorType": "Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation of changes:**\n\n1. **diagnosis**: \"Neurofibromatosis\" (broad term) \u2192 \"Neurofibromatosis type 1\" (more specific). This is the most common form of neurofibromatosis and matches the controlled terminology in the schema.\n\n2. **assay**: \"DNA sequencing\" (broad term) \u2192 \"whole genome sequencing\" (more specific). This narrows the general DNA sequencing method to a specific type that is commonly used and matches the controlled terminology.\n\n3. **tumorType**: \"Neurofibroma\" remains unchanged as it already matches an exact value in the controlled terminology and is appropriately specific for this context.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3029,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 206
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01VcHmS39K8dvSE91FpZijmv",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation of changes:**\n\n1. **diagnosis**: \"Neurofibromatosis\" (broad term) \u2192 \"Neurofibromatosis type 1\" (more specific). This is the most common form of neurofibromatosis and matches the controlled terminology in the schema.\n\n2. **assay**: \"DNA sequencing\" (broad term) \u2192 \"whole genome sequencing\" (more specific). This narrows the general DNA sequencing method to a specific type that is commonly used and matches the controlled terminology.\n\n3. **tumorType**: \"Neurofibroma\" remains unchanged as it already matches an exact value in the controlled terminology and is appropriately specific for this context."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3029,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 206
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3029,
          "output_tokens": 206,
          "total_tokens": 3235
        }
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "NF",
          "assay": "exome sequencing",
          "tumorType": "sarcoma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3023,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 54
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01LPc8F2KS9JAkSqXbpfgVaV",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}\n```"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3023,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 54
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3023,
          "output_tokens": 54,
          "total_tokens": 3077
        }
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Neurofibromatoses",
          "assay": "assay by high throughput sequencer",
          "tumorType": "Nerve Sheath Neoplasm"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3038,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 62
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_0194Rdti913dF2Nf1fEZCWmC",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Malignant Peripheral Nerve Sheath Tumor\"\n}\n```"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3038,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 62
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3038,
          "output_tokens": 62,
          "total_tokens": 3100
        }
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurocutaneous syndrome",
          "assay": "spectroscopy",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurocutaneous syndrome\" is a broad term that encompasses several conditions. Based on the available controlled terminology, \"Neurofibromatosis type 1\" is the most common and representative neurocutaneous syndrome in the schema. (Note: If more context were available, other options like \"NF2-related schwannomatosis\" or \"Schwannomatosis\" could also be appropriate neurocutaneous syndromes.)\n\n2. **assay**: \"spectroscopy\" is a broad term. From the available controlled terminology, \"FTIR spectroscopy\" (Fourier-Transform Infrared Spectroscopy) is the specific spectroscopy method listed in the schema.\n\n3. **tumorType**: \"unknown\" was corrected to \"Unknown\" to match the exact capitalization in the controlled terminology enum values.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3023,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 246
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01VEk2p3LDndyExbhT5hkAnw",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"FTIR spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurocutaneous syndrome\" is a broad term that encompasses several conditions. Based on the available controlled terminology, \"Neurofibromatosis type 1\" is the most common and representative neurocutaneous syndrome in the schema. (Note: If more context were available, other options like \"NF2-related schwannomatosis\" or \"Schwannomatosis\" could also be appropriate neurocutaneous syndromes.)\n\n2. **assay**: \"spectroscopy\" is a broad term. From the available controlled terminology, \"FTIR spectroscopy\" (Fourier-Transform Infrared Spectroscopy) is the specific spectroscopy method listed in the schema.\n\n3. **tumorType**: \"unknown\" was corrected to \"Unknown\" to match the exact capitalization in the controlled terminology enum values."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3023,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 246
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3023,
          "output_tokens": 246,
          "total_tokens": 3269
        }
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunoassay",
          "tumorType": "neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Changes made:**\n- `diagnosis`: \"Not Applicable\" - No change needed (already matches exact enum value)\n- `assay`: \"immunoassay\" - No change needed (already matches exact enum value)\n- `tumorType`: \"neurofibroma\" \u2192 \"Neurofibroma\" - Corrected capitalization to match the exact controlled terminology value in the Target Schema",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3025,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 134
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01DnJVBtU99chLSJEtm4cvxH",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Changes made:**\n- `diagnosis`: \"Not Applicable\" - No change needed (already matches exact enum value)\n- `assay`: \"immunoassay\" - No change needed (already matches exact enum value)\n- `tumorType`: \"neurofibroma\" \u2192 \"Neurofibroma\" - Corrected capitalization to match the exact controlled terminology value in the Target Schema"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3025,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 134
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3025,
          "output_tokens": 134,
          "total_tokens": 3159
        }
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "neurofibromatosis",
          "assay": "plate based reporter assay",
          "tumorType": "benign neurofibroma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"massively parallel reporter assay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3031,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 56
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_017PRNNqTREn7XWJDK9meZix",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"massively parallel reporter assay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```"
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3031,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 56
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3031,
          "output_tokens": 56,
          "total_tokens": 3087
        }
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "RASopathy",
          "assay": "immunoassay",
          "tumorType": "NFIB"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"RASopathy\" is a broad term referring to a group of genetic syndromes caused by mutations in the RAS/MAPK pathway. I narrowed this to \"Noonan Syndrome\", which is one of the most common RASopathies and is included in the controlled terminology.\n\n2. **assay**: \"immunoassay\" is already a specific term in the controlled vocabulary and matches exactly, so no change was needed.\n\n3. **tumorType**: \"NFIB\" appears to be an abbreviation or broad reference. Based on the context and available controlled terminology, I narrowed this to \"Neurofibroma\", which is a specific tumor type commonly associated with neurofibromatosis conditions.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3026,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 222
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01FPT23B47zcFS2L83vV9B5S",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Noonan Syndrome\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"RASopathy\" is a broad term referring to a group of genetic syndromes caused by mutations in the RAS/MAPK pathway. I narrowed this to \"Noonan Syndrome\", which is one of the most common RASopathies and is included in the controlled terminology.\n\n2. **assay**: \"immunoassay\" is already a specific term in the controlled vocabulary and matches exactly, so no change was needed.\n\n3. **tumorType**: \"NFIB\" appears to be an abbreviation or broad reference. Based on the context and available controlled terminology, I narrowed this to \"Neurofibroma\", which is a specific tumor type commonly associated with neurofibromatosis conditions."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3026,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 222
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 3026,
          "output_tokens": 222,
          "total_tokens": 3248
        }
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "NF",
          "assay": "medical imaging",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"NF\" is a broad abbreviation that could refer to multiple neurofibromatosis conditions. I narrowed it to \"Neurofibromatosis type 1\" as it is the most common form of NF and the most likely intended value when \"NF\" is used generically.\n\n2. **assay**: \"medical imaging\" is a very broad term. I narrowed it to \"conventional MRI\" as this is one of the most commonly used medical imaging modalities in neurofibromatosis research and clinical practice, and it matches the controlled terminology in the schema.\n\n3. **tumorType**: \"unknown\" was corrected to \"Unknown\" to match the exact capitalization in the controlled terminology enum values.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3019,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 220
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01NhDAzSJzghpUuCPRMYzH5j",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"NF\" is a broad abbreviation that could refer to multiple neurofibromatosis conditions. I narrowed it to \"Neurofibromatosis type 1\" as it is the most common form of NF and the most likely intended value when \"NF\" is used generically.\n\n2. **assay**: \"medical imaging\" is a very broad term. I narrowed it to \"conventional MRI\" as this is one of the most commonly used medical imaging modalities in neurofibromatosis research and clinical practice, and it matches the controlled terminology in the schema.\n\n3. **tumorType**: \"unknown\" was corrected to \"Unknown\" to match the exact capitalization in the controlled terminology enum values."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3019,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 220
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 3019,
          "output_tokens": 220,
          "total_tokens": 3239
        }
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "neurocristopathy",
          "assay": "transcriptomics",
          "tumorType": "neurolemmoma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"transcriptomics\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurocristopathy\" is a broad term referring to disorders of neural crest-derived tissues. Since the most common neurocristopathy in the provided enum is Neurofibromatosis type 1 (NF1), which affects neural crest-derived cells and is well-represented in the schema, I narrowed it to \"Neurofibromatosis type 1\".\n\n2. **assay**: \"transcriptomics\" is already an exact match in the Target Schema enum, so no change was needed.\n\n3. **tumorType**: \"neurolemmoma\" is a broad/alternative term for schwannoma (a tumor of Schwann cells). The precise term in the controlled vocabulary is \"Schwannoma\", so I narrowed it to that exact value.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3027,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 239
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01C71az9s7gRwaNURceXwXut",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"transcriptomics\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of corrections:**\n\n1. **diagnosis**: \"neurocristopathy\" is a broad term referring to disorders of neural crest-derived tissues. Since the most common neurocristopathy in the provided enum is Neurofibromatosis type 1 (NF1), which affects neural crest-derived cells and is well-represented in the schema, I narrowed it to \"Neurofibromatosis type 1\".\n\n2. **assay**: \"transcriptomics\" is already an exact match in the Target Schema enum, so no change was needed.\n\n3. **tumorType**: \"neurolemmoma\" is a broad/alternative term for schwannoma (a tumor of Schwann cells). The precise term in the controlled vocabulary is \"Schwannoma\", so I narrowed it to that exact value."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3027,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 239
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 3027,
          "output_tokens": 239,
          "total_tokens": 3266
        }
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "phakomatosis",
          "assay": "viability assay",
          "tumorType": "tumor of cranial and spinal nerves"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of narrowing:**\n\n1. **diagnosis**: \"phakomatosis\" is a broad term referring to neurocutaneous syndromes. Given the context of the target schema which focuses on NF-related conditions, this has been narrowed to \"Neurofibromatosis type 1\" (the most common phakomatosis in this domain).\n\n2. **assay**: \"viability assay\" is a general term that has been narrowed to the more specific \"cell viability assay\" which is the exact controlled terminology value in the schema.\n\n3. **tumorType**: \"tumor of cranial and spinal nerves\" is a broad anatomical/pathological description that has been narrowed to \"Schwannoma\", which is the most common tumor type affecting cranial and spinal nerves in the context of this schema's focus on neurofibromatosis and schwannomatosis conditions.",
          "model_id": "global.anthropic.claude-sonnet-4-5-20250929-v1:0",
          "usage": {
            "input_tokens": 3031,
            "cache_creation_input_tokens": 0,
            "cache_read_input_tokens": 0,
            "output_tokens": 255
          },
          "attempt": 1,
          "raw_response": {
            "model": "claude-sonnet-4-5-20250929",
            "id": "msg_bdrk_01XgVEEJPjSPm3ExT5TqGYhm",
            "type": "message",
            "role": "assistant",
            "content": [
              {
                "type": "text",
                "text": "```json\n{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}\n```\n\n**Explanation of narrowing:**\n\n1. **diagnosis**: \"phakomatosis\" is a broad term referring to neurocutaneous syndromes. Given the context of the target schema which focuses on NF-related conditions, this has been narrowed to \"Neurofibromatosis type 1\" (the most common phakomatosis in this domain).\n\n2. **assay**: \"viability assay\" is a general term that has been narrowed to the more specific \"cell viability assay\" which is the exact controlled terminology value in the schema.\n\n3. **tumorType**: \"tumor of cranial and spinal nerves\" is a broad anatomical/pathological description that has been narrowed to \"Schwannoma\", which is the most common tumor type affecting cranial and spinal nerves in the context of this schema's focus on neurofibromatosis and schwannomatosis conditions."
              }
            ],
            "stop_reason": "end_turn",
            "stop_sequence": null,
            "usage": {
              "input_tokens": 3031,
              "cache_creation_input_tokens": 0,
              "cache_read_input_tokens": 0,
              "output_tokens": 255
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 3031,
          "output_tokens": 255,
          "total_tokens": 3286
        }
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.4666666666666667,
      "min_score": 0.0,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 54.37057161331177,
    "token_usage": {
      "input_tokens": 30272,
      "output_tokens": 1694,
      "total_tokens": 31966
    }
  }
}